12 Best Genomics Stocks to Invest In

Page 10 of 11

2. GeneDx Holdings Corp. (NASDAQ:WGS)

Number of Hedge Fund Holders: 34 

Analysts’ Upside Potential as of December 24: 20.43%                            

GeneDx Holdings Corp. (NASDAQ:WGS) is among the Best Genomics Stocks.

TheFly reported that on December 22, 2025, GeneDx Holdings Corp. (NASDAQ:WGS) lifted its price objective at Canaccord from $160 to $170. Canaccord continued to rate the shares as a Buy. The firm stated that the industry’s momentum, which started in the second half of 2025, can continue into 2026 and gave a preview of its coverage of life science instruments and diagnostics. Canaccord noted that it had the strongest conviction in the company’s risk-reward profile and potential for share price growth among the businesses it covered.

Separately, on December 15, 2025, Wells Fargo boosted its target price for GeneDx Holdings Corp. (NASDAQ:WGS) from $140 to $155. The stock was rated Equal Weight by Wells Fargo. According to the firm, there is potential for improvement due to less ambiguity surrounding U.S. policy on pharmaceuticals and already solid forward growth projections. Wells Fargo stated that under these conditions, it supports the structure for tool firms.

In the most recent quarter, President and CEO of the business, Stueland, noted the company’s plan to push forward high-profitable growth by announcing an increase in the 2025 revenue projection to between $425 million and $428 million.

GeneDx Holdings Corp. (NASDAQ:WGS) provides health insights to guide treatment, promote drug discovery, and aid in diagnosis. The business is in a unique position to make precision medicine the norm by accelerating the application of genomic and extensive clinical data.

Page 10 of 11